Change point analyses in prodromal Alzheimer’s disease

Change point analyses in prodromal Alzheimer’s disease

Change point analysis can reveal when a biomarker starts to diverge from the pattern of normal aging. This paper analyzes several biomarkers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to estimate the sequence and timing of their change points relative to a subsequent clinical diagno...

Full description

Bibliographic Details
Main Authors:	Alvin H. Bachman, Babak A. Ardekani
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Biomarkers in Neuropsychiatry
Subjects:	Change Point MCI ADNI Alzheimer’s disease Hippocampus Ventricles
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666144620300186

Similar Items

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
by: Fayçal Ben Bouallègue, et al.
Published: (2017-04-01)

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
by: Liana G. Apostolova, et al.
Published: (2014-01-01)

The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
by: Silke White, et al.
Published: (2023-07-01)

Association of cancer history with Alzheimer’s disease onset and structural brain changes
by: Kelly Nicole Holohan Nudelman, et al.
Published: (2014-10-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
by: Kazushi Suzuki, et al.
Published: (2020-01-01)

Rare Variant Analysis and Molecular Dynamics Simulation in Alzheimer’s Disease Identifies Exonic Variants in FLG
by: Weixue Xiong, et al.
Published: (2022-05-01)

Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy
by: Mary M. Ryan, et al.
Published: (2019-10-01)

Brain morphometry in older adults with and without dementia using extremely rapid structural scans
by: Maxwell L. Elliott, et al.
Published: (2023-08-01)

Alzheimer's disease: 3‐Dimensional MRI texture for prediction of conversion from mild cognitive impairment
by: Collin C. Luk, et al.
Published: (2018-01-01)

Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations
by: Julio eAcosta-Cabronero, et al.
Published: (2014-10-01)

Machine learning of brain structural biomarkers for Alzheimer's disease (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population
by: Akihiko Shiino, et al.
Published: (2021-01-01)

A Survey on Classification Algorithms of Brain Images in Alzheimer’s Disease Based on Feature Extraction Techniques
by: Ruhul Amin Hazarika, et al.
Published: (2021-01-01)

Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer’s disease continuum
by: Hillary Protas, et al.
Published: (2023-03-01)

Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau‐PET load in cognitively intact older adults
by: Jolien Schaeverbeke, et al.
Published: (2022-01-01)

Role of depression in Alzheimer’s disease
by: Anand Bhogaraju
Published: (2015-01-01)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
by: Erik D. Huckvale, et al.
Published: (2021-10-01)

Quantitative phenotype scan statistic (QPSS) reveals rare variant associations with Alzheimer’s disease endophenotypes
by: Yuriko Katsumata, et al.
Published: (2020-05-01)

A TREML2 missense variant influences specific hippocampal subfield volumes in cognitively normal elderly subjects
by: Si‐Yu Wang, et al.
Published: (2020-04-01)

Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
by: Nancy Maserejian, et al.
Published: (2019-12-01)

Signal and Texture Features from T2 Maps for the Prediction of Mild Cognitive Impairment to Alzheimer’s Disease Progression
by: Alejandro I. Trejo-Castro, et al.
Published: (2021-07-01)

The Utility of Age-Specific Cut-offs for Visual Rating of Medial Temporal Atrophy in classifying Alzheimer’s disease, MCI and Cognitively Normal Elderly Subjects
by: Ranjan eDuara, et al.
Published: (2013-09-01)

Alzheimer’s Disease-Related Genes Identified by Linking Spatial Patterns of Pathology and Gene Expression
by: Roger Mullins, et al.
Published: (2022-06-01)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
by: Milap Anil Nowrangi, et al.
Published: (2015-01-01)

FILTER FEATURE SELECTION ANALYSIS TO DETERMINE THE CHARACTERISTICS OF DEMENTIA
by: Savaş OKYAY, et al.
Published: (2021-04-01)

Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging
by: Xiang Hu, et al.
Published: (2023-03-01)

An eXplainability Artificial Intelligence approach to brain connectivity in Alzheimer's disease
by: Nicola Amoroso, et al.
Published: (2023-08-01)

Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease
by: Miriam Punzi, et al.
Published: (2024-03-01)

System-Level Analysis of Alzheimer’s Disease Prioritizes Candidate Genes for Neurodegeneration
by: Jeffrey L. Brabec, et al.
Published: (2021-04-01)

Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease
by: Elena Galea, et al.
Published: (2022-05-01)

Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
by: Azhaar Ashraf, et al.
Published: (2019-03-01)

ComBat Harmonization: Empirical Bayes versus fully Bayes approaches
by: Maxwell Reynolds, et al.
Published: (2023-01-01)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
by: Sacco G, et al.
Published: (2012-12-01)

Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
by: Xi-chen Zhu, et al.
Published: (2020-09-01)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
by: Dandan Chen, et al.
Published: (2023-06-01)

Selection bias in the reported performances of AD classification pipelines
by: Alex F. Mendelson, et al.
Published: (2017-01-01)

Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity
by: Hao Hu, et al.
Published: (2018-05-01)

The accuracy and robustness of plasma biomarker models for amyloid PET positivity
by: Andréa L. Benedet, et al.
Published: (2022-02-01)

Rethinking Alzheimer’s disease
by: Alexandre de Mendonça
Published: (2012-03-01)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
by: Grace J. Goodwin, et al.
Published: (2023-08-01)

Why looking at the whole hippocampus is not enough – a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer’s disease diagnosis.
by: Aleksandra eMaruszak, et al.
Published: (2014-03-01)